The prevalence and clinical impact of obesity in adults with Marfan syndrome

Silverman, 1995, Life expectancy in the Marfan syndrome, Am J Cardiol, 75, 157, 10.1016/S0002-9149(00)80066-1 Milewicz, 2005, Treatment of aortic disease in patients with Marfan syndrome, Circulation, 111, e150, 10.1161/01.CIR.0000155243.70456.F4 Silverman, 1995, Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival, J Am Coll Cardiol, 26, 1062, 10.1016/0735-1097(95)00258-0 van Karnebeek, 2001, Natural history of cardiovascular manifestations in Marfan syndrome, Arch Dis Child, 84, 129, 10.1136/adc.84.2.129 Jeremy, 1994, Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome, Am J Cardiol, 74, 369, 10.1016/0002-9149(94)90405-7 Baumgartner, 2005, Diagnostic power of aortic elastic properties in young patients with Marfan syndrome, J Thorac Cardiovasc Surg, 129, 730, 10.1016/j.jtcvs.2004.07.019 Wilson, 1999, Endothelial function in Marfan syndrome, Circulation, 99, 909, 10.1161/01.CIR.99.7.909 Nagashima, 2001, Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medical degeneration associated with Marfan's syndrome, Circulation, 18, 282, 10.1161/hc37t1.094856 McGill, 2002, Pathobiological determinants of atherosclerosis in youth (PDAY) research group. Obesity accelerates the progression of coronary atherosclerosis in young men, Circulation, 105, 2712, 10.1161/01.CIR.0000018121.67607.CE Widlansky, 2003, The clinical implications of endothelial dysfunction, J Am Coll Cardiol, 42, 1149, 10.1016/S0735-1097(03)00994-X DePaepe, 1996, Revised diagnostic criteria for the Marfan syndrome, Am J Med Genet, 62, 417, 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S Department of Health & Human Services. Centers for Disease Control & Prevention <cdc.gov/nccdphp/dnpa/obesity_diabetes_states.htm> (Accessed on June 2008). Patel, 2006, Valve-sparing aortic root replacement: Early experience with the De Paulis Valsalva graft in 51 patients, Ann Thorac Surg, 82, 548, 10.1016/j.athoracsur.2006.03.073 Bays, 2005, Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything, Expert Rev Cardiovasc Ther, 3, 393, 10.1586/14779072.3.3.393 Eagleton, 2006, Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during angiotensin II induced aneurysm formation, J Surg Res, 135, 345, 10.1016/j.jss.2006.03.026 Fatini, 2005, ACE DD genotype: A predisposing factor for abdominal aortic aneurysm, Eur J Vasc Endovasc Surg, 29, 227, 10.1016/j.ejvs.2004.12.018 Habashi, 2006, Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome, Science, 312, 117, 10.1126/science.1124287 Touyz, 2004, Reactive oxygen species and angiotensin II signaling in vascular cells – implications in cardiovascular disease, Braz J Med Biol Res, 8, 1263, 10.1590/S0100-879X2004000800018 Rosenkranz, 2004, TGF-beta1 and angiotensin networking in cardiac remodeling, Cardiovasc Res, 63, 423, 10.1016/j.cardiores.2004.04.030 Norgan, 1994, Relative sitting height and the interpretation of the body mass index, Ann Hum Biol, 21, 79, 10.1080/03014469400003092